Business Context and Reporting Period
Company: American Exceptionalism Acquisition Corp. A (AEXA)
Filing Type: Form 10-Q (Unaudited)
Period Ended: June 30, 2026
Business Model: Cayman Islands exempted company (SPAC) formed to effect a business combination. As of the reporting date, the Company has not commenced operations and has not selected a specific target. The Company is an emerging growth company and a shell company.
Key Financial Metrics
| Metric | Value (Six Months Ended June 30, 2026) | Value (Three Months Ended June 30, 2026) |
|---|---|---|
| Net Income | $5,733,720 | $2,822,328 |
| Operating Expenses (G&A) | $440,091 | $288,322 |
| Interest Income (Trust Account) | $6,173,811 | $3,110,650 |
| Cash (Operating) | $226,626 (as of June 30, 2026) | N/A |
| Trust Account Balance | $354,539,973 | N/A |
| Working Capital | $293,903 (Surplus) | N/A |
| Deferred Underwriting Fee | $10,350,000 (Liability) | N/A |
| Advisory Fee Payable | $10,350,000 (Liability) | N/A |
Per Share Data: Basic and diluted net income per share for both Class A and Class B ordinary shares was $0.12 for the six months ended June 30, 2026, and $0.06 for the three months ended June 30, 2026.
Material Changes vs. Prior Period
- Trust Account Growth: The Trust Account balance increased from $348,366,162 at December 31, 2025, to $354,539,973 at June 30, 2026, primarily due to interest earnings of $6,173,811.
- Operating Cash Flow: Net cash used in operating activities was $204,305 for the six months ended June 30, 2026. This reflects net income offset by non-cash interest income and changes in working capital (increases in prepaid expenses and accrued expenses).
- Accretion: The Company recorded accretion of Class A Ordinary Shares to redemption value of $3,110,650 for the quarter and $6,173,811 for the six-month period, increasing the accumulated deficit.
- Liabilities: Accrued expenses increased significantly from $16,168 to $185,646, while accrued offering costs were fully paid down from $85,000 to $0.
Outlook, Risks, and Management Commentary
- Going Concern: Management has concluded that conditions raise substantial doubt about the Company's ability to continue as a going concern. The Company has until September 29, 2027, to consummate a business combination. If unsuccessful, the Company will liquidate. Additional financing may be required to meet working capital needs, though there is no assurance such financing will be available.
- Business Combination Timeline: The Company must complete a business combination within 24 months of the IPO (September 29, 2025), extendable to 27 months if a letter of intent is executed within the initial 24 months.
- Risk Factors: The filing highlights risks related to geopolitical instability (Russia-Ukraine conflict, Middle East tensions) and U.S. trade policy changes (tariffs), which could impact the ability to identify and consummate a target. There is no assurance a business combination will be completed.
- Capital Structure: The Company holds 34,500,000 Class A shares subject to redemption and 14,785,714 Class B founder shares. Founder shares are subject to a lock-up until one year post-combination or until specific price thresholds ($12.00, $15.00, $17.50, $20.00) are met.
Investor Verification Checklist
- Trust Account Yield: Verify the interest rate environment and the specific composition of the Trust Account investments (money market funds/U.S. Treasuries) to assess future accretion potential.
- Liquidity Runway: Confirm the sufficiency of the $226,626 operating cash balance against projected G&A expenses to determine the likelihood of needing a Sponsor loan before the combination deadline.
- Redemption Risk: Assess the potential impact of shareholder redemptions on the available cash for a business combination, noting the $10.28 per share redemption value as of June 30, 2026.
- Deferred Fees: Note the $20.7 million in total deferred fees (underwriting and advisory) payable only upon successful completion of a business combination.
- Extension Options: Review the specific terms for extending the completion window beyond the initial 24-month period and any associated costs or shareholder vote requirements.